BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14989221)

  • 21. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-therapy surveillance and after-care in ovarian cancer.
    von Georgi R; Schubert K; Grant P; Münstedt K
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):228-33. PubMed ID: 15140520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viewing ovarian cancer as a "chronic disease": what exactly does this mean?
    Markman M
    Gynecol Oncol; 2006 Feb; 100(2):229-30. PubMed ID: 16226801
    [No Abstract]   [Full Text] [Related]  

  • 24. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
    Lee HC; Chu CY; Hsiao CH
    J Clin Oncol; 2007 Dec; 25(36):5828-30. PubMed ID: 18089882
    [No Abstract]   [Full Text] [Related]  

  • 25. Ovarian cancer.
    Chobanian N; Dietrich CS
    Surg Clin North Am; 2008 Apr; 88(2):285-99, vi. PubMed ID: 18381114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of regular physical examination in the detection of ovarian cancer recurrence.
    Chan KK; Tam KF; Tse KY; Ngan HY
    Gynecol Oncol; 2008 Aug; 110(2):158-61. PubMed ID: 18544459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late recurrence of malignant tumours 20 years after diagnosis and treatment].
    Chodorowski Z; Sein Anand J; Jassem J; Kopacz A; Kruszewski W; Emerich J; Senkus-Konefka E
    Przegl Lek; 2007; 64(4-5):372-3. PubMed ID: 17724919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical picture of recurrences and metastases of malignant cilioepithelial cysts of the ovaries].
    Vinokurov VL
    Vopr Onkol; 1971; 17(7):31-7. PubMed ID: 5137825
    [No Abstract]   [Full Text] [Related]  

  • 29. The quest for ovarian cancer's Holy Grail: can CA-125 still be the chalice of early detection?
    Karlan BY; McIntosh M
    J Clin Oncol; 2007 Apr; 25(11):1303-4. PubMed ID: 17416848
    [No Abstract]   [Full Text] [Related]  

  • 30. [Follow-up after the treatment of ovarian cancer - really without Ca 125?].
    Freitag P
    Ceska Gynekol; 2012 Dec; 77(6):540-2. PubMed ID: 23521196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.
    Carmignani CP; Sugarbaker PH
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):477-87. PubMed ID: 15161446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage I borderline ovarian tumors.
    Creasman WT; Park R; Norris H; Disaia PJ; Morrow CP; Hreshchyshyn MM
    Obstet Gynecol; 1982 Jan; 59(1):93-6. PubMed ID: 7078855
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
    Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent ovarian granulosa cell tumors: clinical and imaging features.
    Rha SE; Oh SN; Jung SE; Lee YJ; Lee AW; Byun JY
    Abdom Imaging; 2008; 33(1):119-25. PubMed ID: 17624570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
    Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
    Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
    Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E
    Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of epithelial ovarian cancer].
    Langmár Z; Csömör S
    Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent ovarian cancer: when and how to treat.
    Hall M; Rustin G
    Curr Oncol Rep; 2011 Dec; 13(6):459-71. PubMed ID: 22045509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S; Hoskins WJ
    Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.